Thus, MRPL17 is an important pro-cancerous target in NSCLC, driving malignant progression through the regulation of mitochondrial function and cellular redox balance, with COX8A identified as a key mediator. The gene discussed is COX8A; the disease is non-small cell lung carcinoma.